​

Cardlytics (CDLX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CDLX Stock Forecast

Cardlytics stock forecast is as follows: an average price target of $4.13 (represents a 11.32% upside from CDLX’s last price of $3.71) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.

CDLX Price Target

The average price target for Cardlytics (CDLX) is $4.13 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $5.00 to $3.50. This represents a potential 11.32% upside from CDLX's last price of $3.71.

CDLX Analyst Ratings

Buy

According to 4 Wall Street analysts, Cardlytics's rating consensus is 'Buy'. The analyst rating breakdown for CDLX stock is 0 'Strong Buy' (0.00%), 2 'Buy' (50.00%), 1 'Hold' (25.00%), 1 'Sell' (25.00%), and 0 'Strong Sell' (0.00%).

Cardlytics Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 11, 2024Mark MahaneyEvercore ISI$4.00$3.2224.22%7.82%
Aug 16, 2024Luke HortonNorthland Securities$5.00$3.7533.33%34.77%
Aug 15, 2024Omar DessoukyBank of America Securities$3.50$3.69-5.15%-5.66%
Aug 08, 2024Jason KreyerCraig-Hallum$4.00$2.9635.14%7.82%
Aug 08, 2024Luke HortonNorthland Securities$7.00$6.901.45%88.68%
Jun 18, 2024Luke HortonNorthland Securities$14.00$8.2170.63%277.36%
Apr 09, 2024Kyle PetersonNeedham$17.00$14.0121.34%358.22%
Aug 02, 2023Kyle PetersonNeedham$19.00$13.4840.95%412.13%
Nov 02, 2022Kyle PetersonNeedham$14.00$5.70145.61%277.36%
May 03, 2022Jason KreyerCraig-Hallum$50.00$35.8639.43%1247.71%
May 03, 2022Needham$60.00$35.8667.32%1517.25%

The latest Cardlytics stock forecast, released on Oct 11, 2024 by Mark Mahaney from Evercore ISI, set a price target of $4.00, which represents a 24.22% increase from the stock price at the time of the forecast ($3.22), and a 7.82% increase from CDLX last price ($3.71).

Cardlytics Price Target by Period

1M3M12M
# Anlaysts-17
Avg Price Target-$4.00$7.79
Last Closing Price$3.71$3.71$3.71
Upside/Downside-100.00%7.82%109.97%

In the current month, the average price target of Cardlytics stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Cardlytics's last price of $3.71. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Aug 15, 2024Northland SecuritiesBuyBuyHold
Aug 08, 2024NeedhamBuyPositiveDowngrade
Aug 08, 2024Craig-HallumBuyHoldDowngrade
Jun 11, 2024Lake StreetUnderperformUnderperformHold
Jun 11, 2024NeedhamBuyBuyHold
Apr 09, 2024Lake StreetUnderperformUnderperformHold
Apr 09, 2024NeedhamBuyBuyHold
Mar 15, 2024NeedhamBuyBuyHold
Mar 15, 2024Craig-HallumBuyUpgrade
Aug 02, 2023NeedhamBuyBuyHold
Nov 02, 2022NeedhamBuyBuyHold
Nov 02, 2022Wells FargoUnderweightUnderweightHold

Cardlytics's last stock rating was published by Northland Securities on Aug 15, 2024. The company gave CDLX a "Buy" rating, the same as its previous rate.

Cardlytics Financial Forecast

Cardlytics Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Mar 18
Revenue--------$89.17M$79.00M$143.33M$67.93M$82.50M$72.71M$75.41M$67.93M$90.05M$64.98M$58.85M$53.23M$67.08M$46.08M$28.22M$45.51M$69.29M$56.42M$48.73M$35.99M$32.71M
Avg Forecast$76.40M$73.28M$67.94M$61.87M$64.29M$57.77M$75.39M$71.69M$89.55M$80.05M$69.11M$65.06M$83.58M$73.90M$76.05M$64.66M$76.53M$62.09M$62.87M$51.07M$60.89M$38.82M$30.78M$42.96M$64.63M$49.99M$44.06M$36.13M$57.95M
High Forecast$79.11M$75.88M$70.35M$64.06M$66.57M$57.78M$75.39M$74.23M$89.63M$82.89M$71.56M$67.37M$86.54M$73.90M$76.05M$64.66M$76.53M$62.09M$62.87M$51.07M$60.89M$38.82M$30.78M$42.96M$64.63M$49.99M$44.06M$36.13M$69.54M
Low Forecast$71.85M$68.91M$63.89M$58.18M$60.46M$57.77M$75.39M$67.42M$89.50M$75.28M$64.99M$61.18M$78.60M$73.90M$76.05M$64.66M$76.53M$62.09M$62.87M$51.07M$60.89M$38.82M$30.78M$42.96M$64.63M$49.99M$44.06M$36.13M$46.36M
# Analysts11123111311111111111138891277816
Surprise %--------1.00%0.99%2.07%1.04%0.99%0.98%0.99%1.05%1.18%1.05%0.94%1.04%1.10%1.19%0.92%1.06%1.07%1.13%1.11%1.00%0.56%

Cardlytics's average Quarter revenue forecast for Mar 24 based on 1 analysts is $71.69M, with a low forecast of $67.42M, and a high forecast of $74.23M. CDLX's average Quarter revenue forecast represents a -19.60% decrease compared to the company's last Quarter revenue of $89.17M (Dec 23).

Cardlytics EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Mar 18
# Analysts11123111311111111111138891277816
EBITDA--------$6.70M$-14.66M$-16.88M$-24.07M$-18.28M$-24.30M$-28.04M$-22.56M$-1.39M$-31.49M$-34.01M$-17.62M$-976.00K$-12.20M$-17.32M$-10.28M$4.82M$-6.20M$-4.99M$-4.86M$-19.14M
Avg Forecast$-29.48M$-28.27M$-26.21M$-23.87M$-24.80M$-22.29M$-29.09M$-27.66M$-34.55M$-30.88M$-26.66M$-25.10M$-32.25M$-13.81M$-14.21M$59.46M$-14.30M$-11.60M$-11.75M$-17.62M$-11.38M$-7.25M$-5.75M$-7.83M$-12.08M$-9.34M$-8.23M$-6.62M$-24.73M
High Forecast$-27.72M$-26.59M$-24.65M$-22.45M$-23.33M$-22.29M$-29.09M$-26.01M$-34.53M$-29.04M$-25.07M$-23.60M$-30.32M$-13.81M$-14.21M$71.35M$-14.30M$-11.60M$-11.75M$-14.10M$-11.38M$-7.25M$-5.75M$-6.27M$-12.08M$-9.34M$-8.23M$-5.30M$-19.79M
Low Forecast$-30.52M$-29.27M$-27.14M$-24.71M$-25.68M$-22.29M$-29.09M$-28.64M$-34.58M$-31.98M$-27.61M$-25.99M$-33.39M$-13.81M$-14.21M$47.57M$-14.30M$-11.60M$-11.75M$-21.15M$-11.38M$-7.25M$-5.75M$-9.40M$-12.08M$-9.34M$-8.23M$-7.94M$-29.68M
Surprise %---------0.19%0.47%0.63%0.96%0.57%1.76%1.97%-0.38%0.10%2.71%2.89%1.00%0.09%1.68%3.01%1.31%-0.40%0.66%0.61%0.73%0.77%

1 analysts predict CDLX's average Quarter EBITDA for Mar 24 to be $-27.66M, with a high of $-26.01M and a low of $-28.64M. This is -513.13% lower than Cardlytics's previous annual EBITDA (Dec 23) of $6.70M.

Cardlytics Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Mar 18
# Analysts11123111311111111111138891277816
Net Income--------$-100.84M$-23.97M$-93.25M$33.04M$-371.86M$49.59M$-126.29M$101.02M$-27.56M$-44.53M$-47.31M$-24.89M$-6.78M$-15.36M$-19.76M$-13.53M$3.43M$-7.75M$-6.51M$-6.31M$-20.05M
Avg Forecast$-15.51M$-17.18M$-19.51M$-22.01M$-23.51M$-28.35M$-23.01M$-21.51M$-11.51M$-32.52M$-36.52M$-39.53M$-40.21M$-48.27M$-43.05M$43.25M$-40.10M$-46.73M$-32.08M$-24.89M$-19.20M$-29.52M$-27.82M$-10.31M$-8.97M$-14.02M$-18.57M$-8.59M$-25.91M
High Forecast$-14.31M$-15.84M$-18.00M$-20.31M$-21.69M$-26.15M$-21.23M$-19.84M$-2.88M$-30.00M$-33.69M$-36.47M$-37.09M$-48.27M$-43.05M$51.90M$-40.10M$-46.73M$-32.08M$-19.92M$-19.20M$-29.52M$-27.82M$-8.25M$-8.97M$-14.02M$-18.57M$-6.88M$-20.73M
Low Forecast$-16.22M$-17.97M$-20.41M$-23.03M$-24.60M$-29.65M$-24.07M$-22.50M$-23.97M$-34.02M$-38.20M$-41.35M$-42.06M$-48.27M$-43.05M$34.60M$-40.10M$-46.73M$-32.08M$-29.87M$-19.20M$-29.52M$-27.82M$-12.37M$-8.97M$-14.02M$-18.57M$-10.31M$-31.09M
Surprise %--------8.76%0.74%2.55%-0.84%9.25%-1.03%2.93%2.34%0.69%0.95%1.47%1.00%0.35%0.52%0.71%1.31%-0.38%0.55%0.35%0.73%0.77%

Cardlytics's average Quarter net income forecast for Jun 23 is $-36.52M, with a range of $-38.20M to $-33.69M. CDLX's average Quarter net income forecast represents a -210.54% decrease compared to the company's last Quarter net income of $33.04M (Mar 23).

Cardlytics SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Mar 18
# Analysts11123111311111111111138891277816
SG&A--------$14.11M$14.16M$15.21M$38.07M$36.89M$38.26M$42.97M$38.07M$36.08M$36.81M$33.95M$25.38M$23.80M$24.19M$22.14M$21.71M$21.53M$23.29M$19.39M$16.34M$14.80M
Avg Forecast$34.66M$33.24M$30.82M$28.07M$29.17M$26.21M$34.20M$32.52M$40.63M$36.32M$31.35M$29.52M$37.92M$34.87M$35.89M$49.84M$36.11M$29.30M$29.67M$25.38M$28.74M$18.32M$14.53M$16.54M$30.50M$23.59M$20.79M$22.24M$19.12M
High Forecast$35.89M$34.42M$31.91M$29.06M$30.20M$26.21M$34.20M$33.68M$40.66M$37.60M$32.46M$30.56M$39.26M$34.87M$35.89M$59.81M$36.11M$29.30M$29.67M$30.45M$28.74M$18.32M$14.53M$19.85M$30.50M$23.59M$20.79M$26.68M$22.94M
Low Forecast$32.59M$31.26M$28.98M$26.39M$27.43M$26.21M$34.20M$30.58M$40.60M$34.15M$29.48M$27.76M$35.66M$34.87M$35.89M$39.87M$36.11M$29.30M$29.67M$20.30M$28.74M$18.32M$14.53M$13.23M$30.50M$23.59M$20.79M$17.79M$15.29M
Surprise %--------0.35%0.39%0.48%1.29%0.97%1.10%1.20%0.76%1.00%1.26%1.14%1.00%0.83%1.32%1.52%1.31%0.71%0.99%0.93%0.73%0.77%

Cardlytics's average Quarter SG&A projection for Mar 24 is $32.52M, based on 1 Wall Street analysts, with a range of $30.58M to $33.68M. The forecast indicates a 130.49% rise compared to CDLX last annual SG&A of $14.11M (Dec 23).

Cardlytics EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Mar 18
# Analysts11123111311111111111138891277816
EPS--------$-2.56$-0.63$-2.67$1.02$-11.13$1.50$-3.75$2.99$-0.83$-1.35$-1.43$-0.85$-0.24$-0.56$-0.73$-0.51$0.13$-0.33$-0.29$-0.28$-1.54
Avg Forecast$-0.31$-0.34$-0.39$-0.44$-0.47$-0.57$-0.46$-0.43$-0.23$-0.65$-0.73$-0.79$-0.80$-0.98$-0.88$-0.92$-0.82$-0.95$-0.65$-0.58$-0.39$-0.60$-0.57$-0.37$-0.18$-0.29$-0.38$-0.59$-0.80
High Forecast$-0.29$-0.32$-0.36$-0.41$-0.43$-0.52$-0.42$-0.40$-0.06$-0.60$-0.67$-0.73$-0.74$-0.98$-0.88$-0.92$-0.82$-0.95$-0.65$-0.58$-0.39$-0.60$-0.57$-0.37$-0.18$-0.29$-0.38$-0.59$-0.64
Low Forecast$-0.32$-0.36$-0.41$-0.46$-0.49$-0.59$-0.48$-0.45$-0.48$-0.68$-0.76$-0.83$-0.84$-0.98$-0.88$-0.92$-0.82$-0.95$-0.65$-0.58$-0.39$-0.60$-0.57$-0.37$-0.18$-0.29$-0.38$-0.59$-0.96
Surprise %--------11.13%0.97%3.66%-1.29%13.85%-1.52%4.27%-3.26%1.02%1.42%2.19%1.47%0.61%0.93%1.29%1.39%-0.71%1.16%0.77%0.47%1.93%

According to 1 Wall Street analysts, Cardlytics's projected average Quarter EPS for Jun 23 is $-0.73, with a low estimate of $-0.76 and a high estimate of $-0.67. This represents a -171.57% decrease compared to CDLX previous annual EPS of $1.02 (Mar 23).

Cardlytics Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ADVAdvantage Solutions$3.29$6.0082.37%Hold
EEXEmerald$4.76$7.9065.97%Buy
CMPRCimpress$78.53$120.0052.81%
IASIntegral Ad Science$10.45$14.6740.38%Buy
QNSTQuinStreet$22.25$29.5032.58%Buy
CRTOCriteo$42.30$55.8031.91%Buy
OMCOmnicom Group$88.97$110.2523.92%Buy
BOCBoston Omaha$14.61$17.0016.36%Buy
DLXDeluxe$23.27$27.0016.03%Buy
CDLXCardlytics$3.84$4.137.55%Buy
IPGInterpublic Group of Companies$29.17$28.50-2.30%Buy
CTVInnovid$3.06$2.50-18.30%Buy

CDLX Forecast FAQ

Is Cardlytics a good buy?

Yes, according to 4 Wall Street analysts, Cardlytics (CDLX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 50.00% of CDLX's total ratings.

What is CDLX's price target?

Cardlytics (CDLX) average price target is $4.13 with a range of $3.5 to $5, implying a 11.32% from its last price of $3.71. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Cardlytics stock go up soon?

According to Wall Street analysts' prediction for CDLX stock, the company can go up by 11.32% (from the last price of $3.71 to the average price target of $4.13), up by 34.77% based on the highest stock price target, and down by -5.66% based on the lowest stock price target.

Can Cardlytics stock reach $6?

CDLX's average twelve months analyst stock price target of $4.13 does not support the claim that Cardlytics can reach $6 in the near future.

What are Cardlytics's analysts' financial forecasts?

Cardlytics's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $269.15M (high $273.97M, low $261.04M), average EBITDA is $-104M (high $-101M, low $-106M), average net income is $-96.387M (high $-88.917M, low $-101M), average SG&A $122.1M (high $124.29M, low $118.42M), and average EPS is $-1.927 (high $-1.777, low $-2.015). CDLX's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $279.5M (high $289.39M, low $262.83M), average EBITDA is $-108M (high $-101M, low $-112M), average net income is $-74.208M (high $-68.456M, low $-77.623M), average SG&A $126.8M (high $131.28M, low $119.24M), and average EPS is $-1.483 (high $-1.368, low $-1.552).

Did the CDLX's actual financial results beat the analysts' financial forecasts?

Based on Cardlytics's last annual report (Dec 2023), the company's revenue was $309.2M, beating the average analysts forecast of $303.78M by 1.79%. Apple's EBITDA was $26.46M, missing the average prediction of $-117M by -122.58%. The company's net income was $-135M, beating the average estimation of $-120M by 12.18%. Apple's SG&A was $57.42M, missing the average forecast of $137.81M by -58.33%. Lastly, the company's EPS was $-3.69, beating the average prediction of $-2.4 by 53.74%. In terms of the last quarterly report (Dec 2023), Cardlytics's revenue was $89.17M, missing the average analysts' forecast of $89.55M by -0.43%. The company's EBITDA was $6.7M, missing the average prediction of $-34.548M by -119.38%. Cardlytics's net income was $-101M, beating the average estimation of $-11.506M by 776.36%. The company's SG&A was $14.11M, missing the average forecast of $40.63M by -65.27%. Lastly, the company's EPS was $-2.56, beating the average prediction of $-0.23 by 1013.04%